USMJ To Meet With ALYI and LEXG Later This Week In Phoenix On Lithium Technology And Cannabis Point of Sale System
June 13 2017 - 10:16AM
InvestorsHub NewsWire
DALLAS, TX - June 13, 2017
- InvestorsHub NewsWire - North American Cannabis Holdings, Inc.
(OTC
PINK: USMJ) recently announced a deal shift in the planned
transaction with Alternet Systems, Inc. (USOTC:ALYI)
in conjunction with the acquisition of the controlling interest in
USMJ by American Cannabis Innovations Conglomerated ("ACI").
The ACI acquisition is part of ACI's overall strategy to acquire
early stage, undervalued businesses with intellectual properties
validated by market tests, and commercial or consumer sales. USMJ
plans to acquire ALYI’s Point of Sale (POS) technology to further
develop and market test a Cannabis Industry specific POS.
USMJ had previously planned to maintain the POS technology within
ALYI and orchestrate an equity swap between the two Companies.
Alternatively, ALYI has entered into an agreement to go a different
direction acquiring a private Lithium Intellectual Property Company
that has entered into a strategic agreement with Lithium
Exploration Group, Inc. (USOTC:LEXG),
among other strategic developments. USMJ, ALYI and LEXG will
all meet later this week near LEXG’s home city of operation in
Phoenix, AZ.
Learn More About USMJ: growusmj.com
Disclaimer/Safe Harbor: This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies’ contracts, the companies’ liquidity position, the
companies’ ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure or prevent any disease.
North American Cannabis Holdings Contact:
Steven Rash
Phone: +1-972-528-0162
Email: Info@growusmj.com